Cargando…
Somatostatin analogues labeled with copper radioisotopes: current status
Peptide receptor radionuclide therapy (PRRT) is a promising way to treat patients with inoperable tumors or metastatic neuroendocrine tumors. This therapeutic strategy is using radiolabeled peptides, which are capable of selective biding to receptors overexpressed in the cancer cells. One of the gro...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533839/ https://www.ncbi.nlm.nih.gov/pubmed/28804185 http://dx.doi.org/10.1007/s10967-017-5323-x |
_version_ | 1783253680798040064 |
---|---|
author | Marciniak, Aleksandra Brasuń, Justyna |
author_facet | Marciniak, Aleksandra Brasuń, Justyna |
author_sort | Marciniak, Aleksandra |
collection | PubMed |
description | Peptide receptor radionuclide therapy (PRRT) is a promising way to treat patients with inoperable tumors or metastatic neuroendocrine tumors. This therapeutic strategy is using radiolabeled peptides, which are capable of selective biding to receptors overexpressed in the cancer cells. One of the group of receptor-avid peptide used in the PRRT are the analogues of somatostatin (SST) connected to the complexes of radionuclides (e.g. (90)Y, (177)Lu or (111)In). Many studies have shown that radiopharmaceuticals based on Cu radioisotopes are promising for the diagnosis and treatment of various cancers. This mini-review focuses on recent developments and summarises the results of multiple studies addressing SST agonists and antagonists radiolabeled to Cu radioisotopes. |
format | Online Article Text |
id | pubmed-5533839 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-55338392017-08-11 Somatostatin analogues labeled with copper radioisotopes: current status Marciniak, Aleksandra Brasuń, Justyna J Radioanal Nucl Chem Article Peptide receptor radionuclide therapy (PRRT) is a promising way to treat patients with inoperable tumors or metastatic neuroendocrine tumors. This therapeutic strategy is using radiolabeled peptides, which are capable of selective biding to receptors overexpressed in the cancer cells. One of the group of receptor-avid peptide used in the PRRT are the analogues of somatostatin (SST) connected to the complexes of radionuclides (e.g. (90)Y, (177)Lu or (111)In). Many studies have shown that radiopharmaceuticals based on Cu radioisotopes are promising for the diagnosis and treatment of various cancers. This mini-review focuses on recent developments and summarises the results of multiple studies addressing SST agonists and antagonists radiolabeled to Cu radioisotopes. Springer Netherlands 2017-06-13 2017 /pmc/articles/PMC5533839/ /pubmed/28804185 http://dx.doi.org/10.1007/s10967-017-5323-x Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Article Marciniak, Aleksandra Brasuń, Justyna Somatostatin analogues labeled with copper radioisotopes: current status |
title | Somatostatin analogues labeled with copper radioisotopes: current status |
title_full | Somatostatin analogues labeled with copper radioisotopes: current status |
title_fullStr | Somatostatin analogues labeled with copper radioisotopes: current status |
title_full_unstemmed | Somatostatin analogues labeled with copper radioisotopes: current status |
title_short | Somatostatin analogues labeled with copper radioisotopes: current status |
title_sort | somatostatin analogues labeled with copper radioisotopes: current status |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533839/ https://www.ncbi.nlm.nih.gov/pubmed/28804185 http://dx.doi.org/10.1007/s10967-017-5323-x |
work_keys_str_mv | AT marciniakaleksandra somatostatinanalogueslabeledwithcopperradioisotopescurrentstatus AT brasunjustyna somatostatinanalogueslabeledwithcopperradioisotopescurrentstatus |